Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02258607
Title Efficacy and Safety of Momelotinib and Momelotinib Combined With Trametinib in Adults With Metastatic KRAS-mutated Non-Small Cell Lung Cancer (NSCLC) Who Have Failed Platinum-Based Chemotherapy Preceded by a Dose-finding Lead-in Phase
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Gilead Sciences
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Duarte California United States Details
Sacramento California United States Details
Boston Massachusetts United States Details
Fairfax Virginia United States Details
Spokane Washington United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field